Yüklüyor......
Efficacy of FOLFOX in Patients with Aggressive Pancreatic Neuroendocrine Tumors After Prior Capecitabine/Temozolomide
BACKGROUND: 5‐fluorouracil, leucovorin, and oxaliplatin (FOLFOX) has activity in pancreatic neuroendocrine tumors (pNETs), but its use is limited, partly because of toxicities. pNETs can often become aggressive over time. We evaluated the efficacy of FOLFOX in patients with aggressive pNETs who had...
Kaydedildi:
| Yayımlandı: | Oncologist |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley & Sons, Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7873336/ https://ncbi.nlm.nih.gov/pubmed/33225478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13611 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|